Most businesses die quietly. They miss a wave, lose relevance and fade out.
Healthify nearly got hit by two in quick succession. First, AI that could do what took the company years to build. Then, a drug which meant you didn't need the discipline anymore.
So Rahel Philipose and Praveen Gopal Krishnan asked
Tushar Vashisht, Healthify's co-founder and CEO, the uncomfortable question directly: if anyone can build an AI coach and a drug can kill your appetite, what exactly are you selling?
This episode is really about three things most people don't know.
One, why people who take Ozempic without a lifestyle program gain almost all the weight back within a year.
Two, what actually happens to a platform business when AI replaces one entire side of it.
And three, why Tushar believes his most dangerous competitor hasn't been founded yet.
We were also joined by
Professor R Srinivasan from IIM Bangalore, who had a very different read on whether Healthify's bet is genius or cope.
______
This episode was produced by Uddantika Kashyap and mixed and mastered by Rajiv CN, our resident sound engineer.
If you liked this episode, share it with your friends, family and colleagues. And if you have thoughts on the discussion, write to us at twobytwo@the-ken.com.